ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Muscle Function"

  • Abstract Number: 1775 • ACR Convergence 2025

    Study Of Type -1 Interferon Gene Signature Markers In Muscle Biopsy Samples Of Patients With IIM

    pradeep sosigowda1, Phani Kumar D1, Megha Uppin1 and Liza rajasekhar2, 1NIMS, Hyderabad, Telangana, India, 2Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India

    Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases primarily affecting skeletal muscle, with potential involvement of other organs. They are classified…
  • Abstract Number: 1209 • ACR Convergence 2025

    Beyond Muscle Strength: Functional Performance Measures Enhance Assessment of Disease Activity in Juvenile Dermatomyositis

    Jia Shi1, Alexander Carpenter2, Christopher Wong2, Qian Wang3, Christian Lood4 and Susan Shenoi5, 1University of Washington, Seattle, WA, 2Division of Rheumatology, Seattle Children's Hospital and Research Center, Seattle, 3Peking Union Medical College Hospital, Beijing, Beijing, China (People's Republic), 4University of Washington, Division of Rheumatology, Seattle, 5Seattle Children's Hospital and Research Center, Mercer Island, WA

    Background/Purpose: To evaluate the measurement properties of functional performance measures (FPMs)—broad jump (BJ) and 10-meter run (10MR)—for assessing muscle function and disease activity in children…
  • Abstract Number: 1208 • ACR Convergence 2025

    Neutrophil Activation in Juvenile Dermatomyositis: Associations with Muscle Function and Disease Progression

    Jia Shi1, Yang Wu2, Aviya Levy3, Ting Wang4, Abhinav Janappareddi5, Payton Hermanson1, Jorge A. Gonzalez-Chapa5, Qian Wang6, Susan Shenoi7 and Christian Lood5, 1University of Washington, Seattle, WA, 21. Chinese Academy of Medical Sciences & Peking Union Medical College; 2. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China; 3. University of Washington, Division of Rheumatology, Seattle, WA, USA, Beijing, China (People's Republic), 3Rady Children's Hospital, San Diego, CA, 4Division of Rheumatology, Seattle Children's Hospital and Research Center, Seattle, 5University of Washington, Division of Rheumatology, Seattle, 6Peking Union Medical College Hospital, Beijing, Beijing, China (People's Republic), 7Seattle Children's Hospital and Research Center, Mercer Island, WA

    Background/Purpose: Juvenile dermatomyositis (JDM) is an inflammatory vasculopathy characterized by muscle weakness and systemic inflammation. This study aimed to investigate the clinical utility of neutrophil…
  • Abstract Number: 0280 • ACR Convergence 2025

    Sera from dermatomyositis patients induce muscle weakness via activation of type I interferon (IFN) receptors.

    Suchada Kaewin1, Cecilia Leijding2, Kristofer Andreasson2, Helene Alexanderson3, Stefano Gastaldello1, Ingrid Lundberg2 and Daniel C. Andersson2, 1Karolinska Institutet, inst fysiologi och farmakologi, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Dermatomyositis (DM) is a major subtype of idiopathic inflammatory myopathies (IIMs) and characterized by muscle weakness, systemic inflammation and cutaneous lesions. Expression of type…
  • Abstract Number: 0560 • ACR Convergence 2024

    Association Between a Self-Report Screening Tool for Sarcopenia (SARC-F) and Disease Activity, Muscle Strength and Muscle Power Measures, Patient-Reported Outcomes and Body Composition in Patients with Spondyloarthritides

    Iuliia Kononenko1, Marius Bedei2, Bjoern Buehring3, Xenofon Baraliakos4 and Uta Kiltz5, 1Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Bochum, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Herne, Germany, 3Bergisches Rheuma-Zentrum, Wuppertal, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-University, D-44649 Herne, Germany

    Background/Purpose: The SARC-F is a self-report screening tool for sarcopenia (Sar) used to identify individuals at risk for poor functional outcomes [1]. The aim of this study was…
  • Abstract Number: 0684 • ACR Convergence 2024

    The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic Sclerosis

    Lucas Dória1, Vanessa Hax2, André Mallmann2, Rafaela Santo3, Leonardo Santos2, Stephanie Pilotti2, Daniel Moraes2, Isabella Boening2, Pedro Glanze2, ODIRLEI MONTICIELO1, Ricardo Xavier4 and Rafael Chakr5, 1Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 2Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 3Health Research and Innovation Science Centre, Klaipeda University, Klaipeda, Lithuania, Porto Alegre, Rio Grande do Sul, Brazil, 4Universidade Federal do Rio Grande do Sul, Porto Alegre/RS, Rio Grande do Sul, Brazil, 5Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

    Background/Purpose: Patients with systemic sclerosis (SSc) often experience body composition changes, including low muscle mass (myopenia), associated with physical disability, hospitalization and death. Our purpose…
  • Abstract Number: 1079 • ACR Convergence 2024

    Early Recognition of Myositis: Time Correlation Between Transaminases and Inflammatory Myopathy in a Community-Based Rheumatology Practice

    Anjali nidhaan, Shannon Iriza, Abbie West, Michael martin and Gauri Pethe, prisma health, columbia, SC

    Background/Purpose: Recognizing muscle breakdown as a potential cause of elevated transaminases is crucial in the primary care setting to facilitate early referral to rheumatology for…
  • Abstract Number: 1182 • ACR Convergence 2024

    Assessing Male Pelvic Floor Contractions Using a Novel External Pressure Device and Ultrasound

    Benedetto Giardulli1, Mirko Job1, Filippo Recenti1, Gaia Leuzzi1, Alessandro Muda2, Ottavia Buccarella1 and Marco Testa1, 1University of Genova, Savona, Italy, 2Lavagna Hospital - Radiology Dept., Genova, Italy

    Background/Purpose: Men with rheumatic and musculoskeletal diseases (RMD) often experience sexual dysfunctions such as pelvic floor pain and erectile dysfunctions, which affect their sexual well-being.…
  • Abstract Number: 2061 • ACR Convergence 2024

    Associations Between Intramyocellular Lipid and Muscle Function in Patients with Osteoarthritis

    Rachel Gillcrist1, Marianna Olave2, Ryan Armbruster3 and Joshua Baker4, 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, 4Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Intramyocellular lipids (IMCL), stored within lipid droplets in skeletal muscle cells, serve as an important metabolic fuel source during exercise. Endurance athletes have demonstrated higher…
  • Abstract Number: 2670 • ACR Convergence 2024

    Sera from Patients with Idiopathic Inflammatory Myopathy Induces Muscle Weakness, Mitochondrial Dysfunction and Induction of Cytokines in Isolated Skeletal Muscle

    Cecilia Leijding1, Suchada Kaewin2, Kristofer Andreasson1, Tomas Schiffer1, Angeles Galindo-Feria3, Begum Horuluoglu1, Mattias Carlstrom1, Stefano Gastaldello1, Helene Alexanderson4, Ingrid Lundberg5 and Daniel Andersson6, 1Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, 3Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 4Karolinska University Hospital, Stockholm, Sweden, 5Karolinska Universitetssjukhuset, Karolinska Institutet, Stockholm, Sweden, 6Karolinska Institutet, Solna, Sweden

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a group of systemic autoimmune inflammatory muscle disorders characterized by symmetrical skeletal muscle weakness and accelerated fatigue. Although signs…
  • Abstract Number: 1971 • ACR Convergence 2023

    Muscle Pathology in Patients with Primary Biliary Cholangitis

    Jose Cesar Milisenda1, Iago Pinal-Fernandez2, Katherine Pak2, Maria Casal-Dominguez3, Yaiza Duque-Jaimez4, Gloria Garrabou1, Sandra Muñoz-Braceras5, Mariona Guitart-Manpel1, Jose Jiram Torres-Ruiz5, Ester Tobias4, Maria Dolores Cano4, Iban Aldecoa4, Josep Maria Grau1 and Andrew Mammen3, 1Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Spain, 2National Institutes of Health, Bethesda, MD, 3NIH, Bethesda, MD, 4Hospital Clínic de Barcelona, Barcelona, Spain, 5Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that primarily affects middle-aged women. It is characterized by elevated serum alkaline phosphatase levels,…
  • Abstract Number: 2467 • ACR Convergence 2023

    Quadriceps Muscle Fat Composition but Not Muscle Energetics Is Associated with Knee Osteoarthritis: Initial Results from the Study of Muscle, Mobility, and Aging

    Giovanna Distefano1, Daniel Evans2, Peggy Cawthon2, John Lynch2, Thomas Link2, Philip Kramer3, Stephanie Harrison2, Bret Goodpaster4, Jane Cauley5, Theresa Mau2, Paul Coen4, Lauren Sparks4 and Nancy Lane6, 1AventisHealth, Orlando, FL, 2University of California San Francisco, San Francisco, CA, 3Wake Forest, Winston-Salem, NC, 4Aventis Health, Orlando, FL, 5University of Pittsburgh, Pittsburgh, PA, 6University of California, Hillsborough, CA

    Background/Purpose: Osteoarthritis (OA) remains the most common cause of joint pain and disability with age, and to date, effective treatments to reduce pain and slow…
  • Abstract Number: 0302 • ACR Convergence 2023

    Remission in Anti-HMGCR Positive Immune-mediated Necrotizing Myopathy Without the Use of Glucocorticoids: A Multicentric Study of 24 Patients

    David Martinez-Lopez1, Cristina Corrales Selaya2, Diana Prieto-Peña2, Piotr Szczesny3, Antonella Notarnicola4, Ricardo Blanco5, Ingrid Lundberg6 and Maryam Dastmalchi6, 1Hospital de Sierrallana, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland; Department of Neurology, Medical University of Warsaw, Warsaw, Poland, 4Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 6Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastroenterology, Dermatotology, Rhematology, Karolinska Universitetssjukhuset, Stockholm, Sweden

    Background/Purpose: Statin-induced immune mediated necrotizing myopathy (IMNM) is a subtype of inflammatory myopathy associated with anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) autoantibodies. This condition is characterized by progressive…
  • Abstract Number: 1147 • ACR Convergence 2023

    Blood-Based Biomarkers of Inflammation and Tissue Remodeling Can Discriminate Between Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis and Are Associated with Hand Function

    Helena Port I Linares1, Birte Coppers2, Sara Bayat2, Godonou Elie-Tino2, Larissa Valor-Mendez2, David Simon2, Filippo Fagni2, Giulia Corte2, Anne-Christine Bay-Jensen3, Koray Tascilar2, Axel Hueber4, Verena Schoenau2, Michael Sticherling5, Simon Heinrich6, Daniela Bohr2, Georg Schett7, Arnd Kleyer8, Sigrid Leyendecker6, Signe Holm Nielsen3 and Anna-Maria Liphardt9, 1Nordic Bioscience A/S / University of Copenhagen, Copenhagen, Denmark, 2Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology / Deutsches Zentrum Immuntherapie, Erlangen, Germany, 3Nordic Bioscience, Herlev, Denmark, 4Division of Rheumatology, Klinikum Nürnberg, Paracelsus Medical University / Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, Nürnberg, Germany, 5Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Dermatology, Erlangen, Germany, 6Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Institute of Applied Dynamics, Erlangen, Germany, 7Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 8University Hospital Erlangen, Erlangen, Germany, 9Friedrich-Alexander-University Erlangen-Nuremberg, Internal Medicine 3 - Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany

    Background/Purpose: Inflammatory musculoskeletal diseases including rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are characterized by physical function impairment due to progressive inflammatory and structural changes.…
  • Abstract Number: 1177 • ACR Convergence 2023

    Anti-HMGCR Autoantibody Levels in the Follow-up of Statin-induced Immune-mediated Necrotizing Myopathy: Multicentric Study of 24 Patients

    David Martinez-Lopez1, Cristina Corrales Selaya2, Diana Prieto-Peña2, Piotr Szczesny3, Antonella Notarnicola4, Marcos Lopez-Hoyos5, Ricardo Blanco6, Ingrid Lundberg7 and Maryam Dastmalchi7, 1Hospital de Sierrallana, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland; Department of Neurology, Medical University of Warsaw, Warsaw, Poland, 4Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 5Marques de Valdecilla University Hospital-IDIVAL, Santander, Spain, 6Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 7Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastroenterology, Dermatotology, Rhematology, Karolinska Universitetssjukhuset, Stockholm, Sweden

    Background/Purpose: Statin-induced immune-mediated necrotizing myopathy (IMNM) is associated with anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) autoantibodies. It is characterized by elevated creatine kinase (CK) levels, and severe muscle…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology